'Rulebook of microbial ecology': Pianists launch Concerto to treat eczema, protect crops and get rid of BO

Kyle LaHucik

Senior Reporter

The microbiome world, at least in drug R&D, has had some hiccups this year, with Flagship’s Kaleido Biosciences shutting down and DermBiont pivoting away from …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

'Rulebook of microbial ecology': Pianists launch Concerto to treat eczema, protect crops and get rid of BO

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

CBER's deputy director departs as staff shakeup continues

Will CRISPR matter?

FDA says Ozempic, Wegovy shortage is over

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

'Rule­book of mi­cro­bial ecol­o­gy': Pi­anists launch Con­cer­to to treat eczema, pro­tect crops and get rid of BO

Senior Reporter

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

'Rulebook of microbial ecology': Pianists launch Concerto to treat eczema, protect crops and get rid of BO